Received Feb 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y011215 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | X028613 | — |
No events were reported; Nurse calling to report that a dose of VARIVAX and PROQUAD were administered concomitantly to a 1 year old patient. No clinical events were reported. No PQC. No additional information.; This spontaneous report was received from a registered nurse referring to a 1 year old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies, and concomitant therapies were not reported. On 21-JAN-2025, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # X028613, expiration date: 13-DEC-2025 (strength, dose, dose number, route and anatomical location were not provided) for prophylaxis concomitantly with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) # Y011215, expiration date: 18-DEC-2025 (strength, dose, dose number, route and anatomical location were not provided) for prophylaxis . No clinical events were reported.